Dicerna Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Dicerna Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 587% to $164,307,000. The net income raised on -$112,747,000 and profit margin reached -69%. Total operating expenses were $277,515,000.
Profit Margin
| 2011 | 7.90M | -8.55M | -108.19% |
|---|---|---|---|
| 2012 | 7.01M | -10.12M | -144.28% |
| 2013 | 0 | -18.51M | |
| 2014 | 0 | -47.93M | |
| 2015 | 184K | -62.83M | -34151.63% |
| 2016 | 295K | -59.51M | -20173.9% |
| 2017 | 2.27M | -60.04M | -2637.15% |
| 2018 | 6.17M | -88.85M | -1438.68% |
| 2019 | 23.90M | -120.45M | -503.93% |
| 2020 | 164.30M | -112.74M | -68.62% |
DRNA Income Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 164.30M | 23.90M | 6.17M | 2.27M | 295K | 184K | 0 | 0 | 7.01M | 7.90M |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 164.30M | 23.90M | 6.17M | 2.27M | 295K | 184K | 0 | 0 | 0 | 0 |
Operating exp. | ||||||||||
Research and development | 205.38M | 109.33M | 45.71M | 36.98M | 41.69M | 43.97M | 29.45M | 11.55M | 11.56M | 10.70M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 277.51M | 152.09M | 67.39M | 62.86M | 60.04M | 63.21M | 45.10M | 17.37M | 16.26M | 0 |
Operating income | -113.20M | -128.18M | -61.22M | -60.58M | -59.74M | -63.02M | -45.10M | -17.37M | -9.25M | -7.61M |
Other income (expenses), net | 461K | 7.72M | -27.63M | 539K | 235K | 188K | -2.83M | -1.14M | -871K | 943K |
Income before tax | -112.74M | -120.45M | -88.85M | -60.04M | -59.51M | -62.83M | -47.93M | -18.51M | -10.12M | -8.55M |
Income tax expense | 481K | 7.73M | -27.03M | 539K | 235K | 188K | -2.63M | -188K | 0 | 0 |
Net income | -112.74M | -120.45M | -88.85M | -60.04M | -59.51M | -62.83M | -47.93M | -18.51M | -10.12M | -8.55M |
Earnings per share | ||||||||||
Basic EPS | -1.51 | -1.76 | -1.6 | -2.9 | -2.87 | -3.09 | -2.98 | -1.11 | -4.95 | -2.84 |
Diluted EPS | -1.51 | -1.76 | -1.6 | -2.9 | -2.87 | -3.09 | -2.98 | -1.11 | -4.95 | -2.84 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |